Effect of Ultrasound Guided L1,L2 Paravertebral Block in Decrease the Requirements for Hypotensive Drugs During General Anesthesia in Patients Undergoing Hip Surgeries.
1 other identifier
interventional
74
1 country
1
Brief Summary
The paravertebral block (PVB) is a block of the mixed nerve soon after it exits the intervertebral foramen.(2) It provides intense unilateral analgesia of long duration and has become the primary anesthetic for many applications.(3) Paravertebral Block (PVB) involves injection of local anaesthetic in a space immediately lateral to where the spinal nerves emerge from the intervertebral foramina. This technique is being used increasingly for not only intra-operative and post-operative analgesia but also as a sole anaesthetic technique for carrying out various procedures. This popularity is mainly due to the ease of the technique and fewer complications.(4) The increasing demand for hip arthroplasties over the last decades has sparked the creation of new and innovative anesthetic techniques and analgesic pathways with the goal to support best possible outcomes among this frequently elderly patient population. As a result, today different perioperative treatment pathways are available to physicians and their patients. In this context, the focus has shifted to techniques based on regional anesthetic and analgesic techniques. This trajectory has been fueled by a number of advantages including effective, long-lasting and focused pain control, decreased need for systemic analgesics and earlier mobilization.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Feb 2018
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 27, 2017
CompletedFirst Posted
Study publicly available on registry
February 5, 2018
CompletedStudy Start
First participant enrolled
February 12, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 10, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
May 15, 2018
CompletedMay 17, 2018
May 1, 2018
3 months
December 27, 2017
May 15, 2018
Conditions
Outcome Measures
Primary Outcomes (1)
Dose of hypotensive drugs
Required dose of hypotensive drugs in both groups
One day postoperatively
Secondary Outcomes (2)
Pain assessment
One day postoperatively
Total dose of opioids
One day postoperatively
Other Outcomes (1)
Blood transfusion recorded
One day postoperatively
Study Arms (2)
Paravertebral block Group
ACTIVE COMPARATORPatients will receive single shot L1-L2 PVB before undergoing GA Full monitoring with ECG , NIBP , puls oximetry will be applied. The level between L1 and L2 will be identified using U/S as well as transverse processes depth. Insertion points will be marked 2.5 cm lateral to the superior aspect of corresponding spinous processes, A 22-gauge Tuohy needle will be advanced until it made contact with the transverse process. The needle will be withdrawn slightly and walked off caudally to an additional depth of 1 cm. Once this is reached, 20cc of bupivacaine 0.25% will be injected slowly To control intraoperative blood pressure, fentanyl will be used as well as hypotensive drugs ( propranolol and nitroglycerine and the total dose will be recorded.
General anesthesia Group
ACTIVE COMPARATORPatients will receive only GA All patients in the study will receive GA in the form of propofol 2mg/kg , atracurium 0.5ml/kg ,fentanyl 100 microgram in induction with ETT and mechanical ventilation , full monitoring with ECG , NIBP and puls oximetry will be applied. To control intraoperative BP,fentanyl will be used as well as,hypotensive drugs ( propranolol and nitroglycerine and the total dose will be recorded. To achieve post operative analgesia, intravenous paracetamol( 1gram ) and pethidine IV (50 mg ) will be added when needed
Interventions
An 18G Tuohy needle was inserted perpendicularly at L1,2 to hit the transverse process via an out-of-plane approach. This then directed over the top of the bony structure. The deviation of the needle was kept at 15°. The space was identified using loss of resistance without U/S After negative aspiration, Transverse process visualisation was possible. Distances measured using U/S correlated well with needle depth. Injection of local anaesthetic was visualised as turbulence at L1,2 in all patients. The onset time for this block is 15-25 min
Patients will receive single shot L1-L2 PVB before undergoing GA
Eligibility Criteria
You may qualify if:
- Patients from 20 to 60 years.
- Genders eligible for study: both.
- ASA I-II.
- No contraindications for application of regional anesthesia as Patient refusal, local anesthetic, allergy, local sepsis or infection at puncture site, INR \> 1.5 or \< 12 hours post LMWH.
You may not qualify if:
- Extremes of age.
- ASA III-IV.
- Hypovolemia.
- Increased intracranial pressure.
- Coagulopathy or thrombocytopenia less than 100000/ml.
- Sepsis (increased risk of meningitis).
- Infection at the puncture site.
- Pre-existing neurologic disease.
- Patient refusal.
- History of allergy to local anesthetic.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Cairo Universitylead
- Mohamed, Ahmed A., M.D.collaborator
- Hala Mostafa Gomaacollaborator
- Abdelhamid, Bassant Mohamed, M.D.collaborator
- Mohamed saeid Alicollaborator
Study Sites (1)
Ahmed Abdalla Mohamed
Cairo, 11451, Egypt
MeSH Terms
Interventions
Intervention Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- CARE PROVIDER, INVESTIGATOR
- Masking Details
- The patients were randomized to two groups using a computer-generated list and kept in a sealed envelope into two groups:
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor of Anesthesia&I.C.U and Pain Clinic
Study Record Dates
First Submitted
December 27, 2017
First Posted
February 5, 2018
Study Start
February 12, 2018
Primary Completion
May 10, 2018
Study Completion
May 15, 2018
Last Updated
May 17, 2018
Record last verified: 2018-05
Data Sharing
- IPD Sharing
- Will not share
Via scholar Gate